Articles
Article Tools
 View Full Text |
 Abstract |
 Article as PDF |
 Print this Article |
 Pubmed |
 PMC |
 PubReader |
 Export to Citation |
 Email Alerts |
 Open Access |
Share this article on :
Stats or Metrics
Article
Original Article
Exp Neurobiol 2014; 23(2): 163-168
Published online June 30, 2014
https://doi.org/10.5607/en.2014.23.2.163
© The Korean Society for Brain and Neural Sciences
Isoliquiritigenin, a Chalcone Compound, Enhances Spontaneous Inhibitory Postsynaptic Response
Junsung Woo1,2, Suengmok Cho3 and C. Justin Lee1,2*
1Center for Neural Science and Functional Connectomics, Korea Institute of Science and Technology (KIST), Seoul 136-791, 2Neuroscience Program, University of Science and Technology (UST), Daejeon 305-350, 3Korea Food Research Institute, Seongnam 463-746, Korea
Correspondence to: *To whom correspondence should be addressed.
TEL: 82-2-958-6940, FAX: 82-2-958-7219
e-mail: cjl@kist.re.kr
Abstract
- Go to
- Abstract
Isoliquiritigenin (ILTG) is a chalcone compound and shows various pharmacological properties, including antioxidant and anti-inflammatory activities. In recent study, we have reported a novel role of ILTG in sleep through a positive allosteric modulation of gamma-aminobutyric acid type A (GABAA)-benzodiazepine (BZD) receptors. However, the effect of ILTG in GABAAR-mediated synaptic response in brain has not been tested yet. Here we report that ILTG significantly prolonged the decay of spontaneous inhibitory postsynaptic currents (sIPSCs) mediated by GABAAR in mouse hippocampal CA1 pyramidal neurons without affecting amplitude and frequency of sIPSCs. This enhancement was fully inhibited by flumazenil (FLU), a specific GABAA-BZD receptor antagonist. These results suggest a potential role of ILTG as a modulator of GABAergic synaptic transmission.
Keywords: Isoliquiritigenin, GABAA-BZD receptor, sIPSC
